619 filings
Page 9 of 31
424B5
udx5wdvj 9lml
10 Mar 17
Prospectus supplement for primary offering
12:00am
8-K
5o659k
10 Mar 17
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update
12:00am
8-K
8qglk6cqlc 8sr6g
9 Mar 17
Entry into a Material Definitive Agreement
12:00am
424B5
woa587qbddh8 sw2ea6q
8 Mar 17
Prospectus supplement for primary offering
12:00am
8-K
ux0r0v
6 Mar 17
Other Events
12:00am
8-K
aw1n6e0z aqmnfme2azs
4 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K
lhqh9v
6 Dec 16
TG Therapeutics, Inc. Announces Double & Triple Combination Therapy Data Presentations at the 58th American Society of Hematology Annual Meeting
12:00am
8-K
bk2w4z6r9 9ppwzpho
5 Dec 16
TG Therapeutics, Inc. Announces Preclinical Data Presentations for TGR-1202 at the 58th American Society of Hematology Annual Meeting
12:00am
8-K
m4gzo7ydjf9hexr96
7 Nov 16
TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2016 Financial Results
12:00am
8-K
aaq39ug
13 Oct 16
TG Therapeutics, Inc. Amends the GENUINE Phase 3 Clinical Trial to Accelerate Study Completion by Revising Primary Endpoint to Overall Response Rate
12:00am
CT ORDER
edhyehev3yeaav 3am
4 Oct 16
Confidential treatment order
12:00am
8-K
0ilrvd 1deg
8 Aug 16
TG Therapeutics, Inc. Announces Second Quarter 2016 Financial Results and Business Update
12:00am
8-K
vg3 5ljtnrdz6t
14 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ly8ux11duknzry3
6 Jun 16
Other Events
12:00am
8-K
xuns19vkccas
2 Jun 16
Entry into a Material Definitive Agreement
12:00am